Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
stock777777's Profile
Displaying 1-16 of 16 result(s).
MFST Medifirst Solutions Inc.
12/16/2016 2:19:42 PM
Due to the decrease of inflammatio
MFST Medifirst Solutions Inc.
12/16/2016 2:18:40 PM
Medifirst Solutions, Inc., in respo
MFST Medifirst Solutions Inc.
12/16/2016 2:16:18 PM
Mr. White stated, “I'm very excit
MFST Medifirst Solutions Inc.
12/16/2016 8:45:04 AM
FDA approved product , low OS! MFST
MFST Medifirst Solutions Inc.
12/16/2016 8:44:13 AM
Buying should continue Today! MFST
BREAKOUTS..RUNNERS AND HOT PENNIES
12/16/2016 8:20:33 AM
MFST ready! Accum is UP! News is on
MFST Medifirst Solutions Inc.
12/16/2016 8:10:56 AM
I like Accum/Dist line finally to s (1)
MFST Medifirst Solutions Inc.
12/16/2016 8:09:20 AM
What is latest O/S ? MFST
BCAP Baron Capital Enterprise, INC.
03/08/2012 12:53:40 PM
I am out @.0003 . Good luck everybo
BCAP Baron Capital Enterprise, INC.
03/08/2012 9:41:08 AM
Always have to have an answer to qu
BCAP Baron Capital Enterprise, INC.
03/08/2012 9:35:34 AM
In the past I was hopping that he d
BCAP Baron Capital Enterprise, INC.
03/08/2012 8:42:31 AM
BCAP
BCAP Baron Capital Enterprise, INC.
03/08/2012 8:42:10 AM
Good post kilo!!! IMO all hedge fun
BCAP Baron Capital Enterprise, INC.
03/07/2012 7:57:20 PM
BCAP!!
BCAP Baron Capital Enterprise, INC.
03/07/2012 7:56:56 PM
Somebody sent me e-mail. Thanks .eo
BCAP Baron Capital Enterprise, INC.
03/07/2012 7:51:51 PM
Hi everybody!!! I like it here!!! G

Recent Articles

  • Duolingo Enhances AI Strategy with Strong Quarterly Results
  • Viasat's Financial Rebound: A Game-Changer for Investors
  • Michael Saylor Highlights Bitcoin's Tariff-Free Advantage
  • Capricor Therapeutics Faces Class Action Amid FDA Challenges
  • Class Action Lawsuit Filed for PepGen Inc. Shareholders
  • Hims & Hers Health Investors Encouraged to Act Now for Rights
  • Legal Action Against Fiserv, Inc. for Alleged Securities Fraud
  • Altimmune Faces Class Action Lawsuit: Key Details Enclosed
  • Biohaven Ltd Faces Class Action Lawsuit - What Investors Should Know
  • Investors of iRobot Corporation: Your Chance for Recovery
  • Understanding Recent Legal Challenges Faced by Lineage, Inc.
  • Cryptocurrency Overview: Bitcoin, Ethereum, and the Golden Cross
  • Investors Encouraged to Act Following Lockheed Martin Lawsuit
  • Replimune Group, Inc. Shareholder Rights Information
  • Banco Comercial Português Updates Share Buy-Back Programme
  • Join the Centene Class Action: Deadline Approaching Soon
  • Banco Comercial Português Reports on Share Buy-Back Transactions
  • John Hancock Closed-End Funds: A Deep Dive into Earnings
  • Understanding First BanCorp's Short Interest Changes
  • Understanding Investor Sentiment Towards Regeneron Pharmaceuticals
  • Understanding Short Interest Trends in Northrop Grumman
  • Transform Your Investment: $1000 in Zscaler's Journey
  • Palatin Technologies Executes Reverse Stock Split to Align Stock Price
  • Historic Firearm of Simón Bolívar to Be Auctioned Soon
  • Biglari Holdings Reports Solid Second Quarter Financials
  • Salama Reports Strong H1 2025 Financial Growth and Strategies
  • Marex Group Faces Challenges as Investor Concerns Grow
  • PetSmart Announces New Notes Offering for Financial Growth
  • CleanSpark's Q3 Performance: Revenue Surge Amid Stock Drop
  • John Hancock Funds Announce Impressive Earnings Results
  • Join the Class Action Against Alto Neuroscience Today
  • Dover Corporation Announces Increased Quarterly Dividend
  • Investors Take Action: Class Lawsuit Involving 3D Systems
  • Westwood Holdings Achieves Notable Growth in Latest Earnings
  • RJM & Company Explores New Opportunities at Steel Summit 2025
  • Vestis Corporation Faces Class Action Lawsuit: Key Insights
  • NI Holdings, Inc. Releases Second Quarter Financial Insights
  • Brookfield Property Partners Affirms Commitment with Dividends
  • Olivia Lowery Named to Influential NCBA Family Law Committee
  • Groundbreaking Achievements at Calidi Biotherapeutics Unfold
  • Sarepta Therapeutics Faces Potential Class Action Lawsuit Risks
  • Barnes & Noble Education Addresses Compliance with NYSE Standards
  • Investors of XPLR Infrastructure, LP Could Join Class Action
  • Arcutis Biotherapeutics Announces New Stock Grants to Employees
  • Unlocking the Growth of $1000 in Carlisle Companies Shares
  • Brookfield Property Partners Announces Quarterly Dividends Update
  • DoorDash's Impactful Financials Show Path To Future Success
  • Outdoor Holding Company Sees Growth Amid Challenges in Q1 2026
  • Compass Therapeutics to Reveal Financial Insights on Q2 Performance
  • Compass Therapeutics Set to Share Financial Insights Soon
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site